Delving into the Latest Updates on Amulet Pharmaceuticals, Inc. with Synapse

概览

关联

1

项与 Amulet Pharmaceuticals, Inc. 相关的药物

AMU-301

靶点-

作用机制-

在研机构-

原研机构

Amulet Pharmaceuticals, Inc.

在研适应症-

非在研适应症

胃轻瘫

最高研发阶段终止

首次获批国家/地区-

首次获批日期-

100 项与 Amulet Pharmaceuticals, Inc. 相关的临床结果

登录后查看更多信息

0 项与 Amulet Pharmaceuticals, Inc. 相关的专利（医药）

登录后查看更多信息

1

项与 Amulet Pharmaceuticals, Inc. 相关的文献（医药）

Recent Research Developments in Microbiology

Antimicrobial properties of nitric oxide using diazeniumdiolates as the nitric oxide donor

作者: Cihlar, Ronald L. ; Raulli, Robert ; Hrabie, Joseph A. ; McElhaney-Feser, Gail

A review and discussion.Nitric oxide has been shown to be an antimicrobial agent, but it has not been widely used in clin. therapies or for removal of microbial contamination of products that require sterility.This is in part due to difficulty in developing appropriate delivery systems and its potential for toxicity.Diazeniumdiolates are stable compounds that release nitric oxide at a predictable rate and might prove useful in addressing these problems.The properties of diazeniumdiolates that make them attractive for these applied uses are reviewed.In addition, the antimicrobial effects of nitric oxide are discussed, and recent information concerning the in vitro antimicrobial activity of diazeniumdiolate released nitric oxide is presented.

100 项与 Amulet Pharmaceuticals, Inc. 相关的药物交易

登录后查看更多信息

100 项与 Amulet Pharmaceuticals, Inc. 相关的转化医学

登录后查看更多信息